Ticker
CHRSCompany Name
COHERUS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Inventory | Inventory to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 439.46M | $ 4.51M | 1.03% |
3/31/2025 | $ 371.07M | $ 3.52M | 0.95% |
12/31/2024 | $ 448.53M | $ 113.87M | 25.39% |
9/30/2024 | $ 505M | $ 119.02M | 23.57% |
6/30/2024 | $ 674.86M | $ 112.04M | 16.6% |
3/31/2024 | $ 763.54M | $ 127.62M | 16.71% |
12/31/2023 | $ 629.6M | $ 130.1M | 20.66% |
9/30/2023 | $ 583.78M | $ 145.78M | 24.97% |
6/30/2023 | $ 469.59M | $ 127.83M | 27.22% |
3/31/2023 | $ 402.43M | $ 114.49M | 28.45% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for COHERUS ONCOLOGY INC is calculated as follows: Inventory [ $ 85.96M ] / Assets [ $ 803.73M ]
(=) Inv. to Assets [ 10.7% ]
Minimum
Mar 31, 2025
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 4.46K |
---|---|
min | 0% |
max | 98.39% |
average | 6.09% |
median | 0% |
std | 11.11% |